Position in AGMB
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$29,194,677
New position
Shares Held
2,783,096
first reported quarter
Ownership
5.65%
of shares outstanding
% of Portfolio
8.31%
of 13F equity value
Holder Rank
#2
of 32 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Sanofi holds $351,158,122 across 9 Biotechnology names. AGMB ranks #5 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MGTX |
MeiraGTx Holdings plc
|
12,197,737 | $105,632,402 | |
| 2 | INBX |
Inhibrx Biosciences, Inc.
|
1,157,926 | $77,847,364 | |
| 3 | NVAX |
Novavax Inc
|
6,880,481 | $56,007,115 | |
| 4 | ANAB |
Anaptysbio, Inc
|
821,917 | $45,583,516 | |
| 5 | AGMB |
Agomab Therapeutics NV
This page
|
2,783,096 | $29,194,677 | |
| 6 | MPLT |
MapLight Therapeutics, Inc.
|
912,041 | $18,541,793 | |
| 7 | IMRX |
Immuneering Corp
|
2,708,559 | $14,274,105 | |
| 8 | ELDN |
Eledon Pharmaceuticals, Inc.
|
814,980 | $2,510,138 |
All Filings in AGMB
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,194,677 | 2,783,096 | Shares | Sole | 2026-05-07 | |
| 2026-03-31 | $29,194,677 | 2,783,096 | Shares | Sole | 2026-05-06 | |
| No filing history on record for this holder in this stock. | ||||||